Login to Your Account

Lifted By Higher Product Sales, Amgen Beats Consensus EPS

By Karen Pihl-Carey

Monday, April 25, 2005
Beating Wall Street estimates, Amgen Inc. performed well in the first quarter, reporting strong revenue for most of its products, despite Medicare reimbursement changes. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription